Advanced Medical Solutions Group plc (AIM:AMS) acquired Biomatlante SARL for €8.3 million on December 2, 2019. Under the terms of the transaction, an initial consideration of €8 million in cash, on a debt-free and cash-free basis, to be funded from AMS's existing cash resources. A potential further up to €0.3m is due over the next two years subject to the achievement of certain new product approval milestones. Biomatlante reported a revenue of of more than €4 million, a net profit of approximately €0.2 million and gross assets of approximately €2.4 million as of December 31, 2018. Advanced Medical Solutions Group plc (AIM:AMS) completed the acquisition of Biomatlante SARL on December 2, 2019.